| 0 |
PARANASAL SINUS INJURY |
1 |
0.0588 |
| 1 |
LIP EXFOLIATION |
7 |
0.0053 |
| 2 |
LIP INFECTION |
1 |
0.0047 |
| 3 |
PALATAL SWELLING |
1 |
0.0041 |
| 4 |
PARANASAL SINUS HYPOSECRETION |
1 |
0.0040 |
| 5 |
LIP ERYTHEMA |
3 |
0.0038 |
| 6 |
LIP PAIN |
10 |
0.0035 |
| 7 |
LEIOMYOSARCOMA |
1 |
0.0026 |
| 8 |
GRANULOCYTE COUNT INCREASED |
1 |
0.0025 |
| 9 |
LIP PRURITUS |
2 |
0.0023 |
| 10 |
LIP INJURY |
3 |
0.0023 |
| 11 |
LIP DISORDER |
4 |
0.0021 |
| 12 |
ASPARTATE AMINOTRANSFERASE DECREASED |
1 |
0.0019 |
| 13 |
CHAPPED LIPS |
8 |
0.0018 |
| 14 |
EYE BURNS |
1 |
0.0017 |
| 15 |
CHEILITIS |
8 |
0.0015 |
| 16 |
COELIAC DISEASE |
12 |
0.0012 |
| 17 |
NEUROPSYCHIATRIC SYMPTOMS |
1 |
0.0011 |
| 18 |
PRODUCT CLOSURE REMOVAL DIFFICULT |
1 |
0.0010 |
| 19 |
REACTION TO DRUG EXCIPIENTS |
2 |
0.0009 |
| 20 |
POOR QUALITY DRUG ADMINISTERED |
5 |
0.0008 |
| 21 |
LIP BLISTER |
2 |
0.0007 |
| 22 |
LIP DRY |
6 |
0.0007 |
| 23 |
ORAL MUCOSAL ERUPTION |
1 |
0.0007 |
| 24 |
ORAL MUCOSAL ERYTHEMA |
1 |
0.0006 |
| 25 |
BLOOD CHLORIDE INCREASED |
1 |
0.0006 |
| 26 |
BURNS SECOND DEGREE |
1 |
0.0006 |
| 27 |
LYMPH NODE PAIN |
1 |
0.0005 |
| 28 |
COMPULSIVE SHOPPING |
1 |
0.0005 |
| 29 |
APPLICATION SITE SCAB |
1 |
0.0005 |
| 30 |
PRODUCT PACKAGE ASSOCIATED INJURY |
1 |
0.0004 |
| 31 |
ORAL PRURITUS |
1 |
0.0004 |
| 32 |
PRODUCT COMPLAINT |
11 |
0.0004 |
| 33 |
REACTION TO EXCIPIENT |
1 |
0.0004 |
| 34 |
BRONCHITIS CHRONIC |
1 |
0.0004 |
| 35 |
CANCER PAIN |
1 |
0.0004 |
| 36 |
BLOOD SODIUM INCREASED |
1 |
0.0004 |
| 37 |
GAMBLING DISORDER |
1 |
0.0004 |
| 38 |
LIP SWELLING |
12 |
0.0004 |
| 39 |
ORAL DISCOMFORT |
5 |
0.0004 |
| 40 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 41 |
LYME DISEASE |
1 |
0.0003 |
| 42 |
APPLICATION SITE REACTION |
2 |
0.0003 |
| 43 |
THERMAL BURN |
2 |
0.0003 |
| 44 |
FACIAL BONES FRACTURE |
1 |
0.0003 |
| 45 |
FACE INJURY |
1 |
0.0003 |
| 46 |
PARANASAL SINUS HYPERSECRETION |
1 |
0.0003 |
| 47 |
THYROID MASS |
1 |
0.0003 |
| 48 |
GINGIVAL DISORDER |
1 |
0.0003 |
| 49 |
TONGUE DISCOMFORT |
1 |
0.0002 |
| 50 |
TONGUE DISCOLOURATION |
1 |
0.0002 |
| 51 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
1 |
0.0002 |
| 52 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 53 |
HORMONE LEVEL ABNORMAL |
1 |
0.0002 |
| 54 |
PRODUCT DELIVERY MECHANISM ISSUE |
1 |
0.0002 |
| 55 |
TIC |
1 |
0.0002 |
| 56 |
ASTHENOPIA |
1 |
0.0002 |
| 57 |
CHOKING SENSATION |
1 |
0.0002 |
| 58 |
MACULAR DEGENERATION |
2 |
0.0002 |
| 59 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
0.0002 |
| 60 |
PARAESTHESIA ORAL |
2 |
0.0001 |
| 61 |
PANIC REACTION |
1 |
0.0001 |
| 62 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 63 |
ORAL DISORDER |
1 |
0.0001 |
| 64 |
ARTHROPOD BITE |
1 |
0.0001 |
| 65 |
SUNBURN |
1 |
0.0001 |
| 66 |
OBSESSIVE-COMPULSIVE DISORDER |
1 |
0.0001 |
| 67 |
MIOSIS |
1 |
0.0001 |
| 68 |
ASPHYXIA |
1 |
0.0001 |
| 69 |
FACIAL PAIN |
1 |
0.0001 |
| 70 |
DEPENDENCE |
6 |
0.0001 |
| 71 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 72 |
SQUAMOUS CELL CARCINOMA |
1 |
0.0001 |
| 73 |
LEUKAEMIA |
1 |
0.0001 |
| 74 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 75 |
BRAIN INJURY |
1 |
0.0001 |
| 76 |
EMPHYSEMA |
1 |
0.0001 |
| 77 |
DRY THROAT |
1 |
0.0001 |
| 78 |
DRUG LEVEL DECREASED |
1 |
0.0001 |
| 79 |
PRODUCT ODOUR ABNORMAL |
1 |
0.0001 |
| 80 |
SCRATCH |
1 |
0.0001 |
| 81 |
BODY HEIGHT DECREASED |
1 |
0.0001 |
| 82 |
SKIN LACERATION |
1 |
0.0001 |
| 83 |
ORAL PAIN |
2 |
0.0001 |
| 84 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 85 |
POISONING |
1 |
0.0001 |
| 86 |
ANAPHYLACTIC REACTION |
4 |
0.0001 |
| 87 |
APHONIA |
1 |
0.0001 |
| 88 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 89 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 90 |
COLON CANCER |
1 |
0.0001 |
| 91 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 92 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 93 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 94 |
BACK DISORDER |
1 |
0.0001 |
| 95 |
SCAR |
1 |
0.0001 |
| 96 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 97 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 98 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
2 |
0.0001 |
| 99 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 100 |
PHOTOPHOBIA |
1 |
0.0001 |
| 101 |
INCREASED APPETITE |
1 |
0.0001 |
| 102 |
PRODUCT QUALITY ISSUE |
7 |
0.0001 |
| 103 |
EAR PAIN |
1 |
0.0001 |
| 104 |
CHOKING |
1 |
0.0001 |
| 105 |
ORAL HERPES |
1 |
0.0001 |
| 106 |
SINUS DISORDER |
1 |
0.0001 |
| 107 |
DRUG DEPENDENCE |
8 |
0.0000 |
| 108 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 109 |
DRY MOUTH |
4 |
0.0000 |
| 110 |
EATING DISORDER |
1 |
0.0000 |
| 111 |
MENTAL DISORDER |
2 |
0.0000 |
| 112 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 113 |
TOOTH DISORDER |
1 |
0.0000 |
| 114 |
GLOSSODYNIA |
1 |
0.0000 |
| 115 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 116 |
PRESYNCOPE |
1 |
0.0000 |
| 117 |
NEURALGIA |
1 |
0.0000 |
| 118 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 119 |
LIMB INJURY |
1 |
0.0000 |
| 120 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 121 |
DEMENTIA |
1 |
0.0000 |
| 122 |
FLATULENCE |
2 |
0.0000 |
| 123 |
PANCREATIC CARCINOMA |
1 |
0.0000 |
| 124 |
INTENTIONAL PRODUCT MISUSE |
3 |
0.0000 |
| 125 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 126 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 127 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 128 |
DYSARTHRIA |
1 |
0.0000 |
| 129 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 130 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 131 |
CONDITION AGGRAVATED |
7 |
0.0000 |
| 132 |
SKIN IRRITATION |
1 |
0.0000 |
| 133 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 134 |
HYPERSENSITIVITY |
4 |
0.0000 |
| 135 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 136 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 137 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 138 |
LUNG DISORDER |
1 |
0.0000 |
| 139 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
4 |
0.0000 |
| 140 |
NECK PAIN |
1 |
0.0000 |
| 141 |
EYE PAIN |
1 |
0.0000 |
| 142 |
STOMATITIS |
1 |
0.0000 |
| 143 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 144 |
AMNESIA |
1 |
0.0000 |
| 145 |
SWELLING FACE |
1 |
0.0000 |
| 146 |
DRY SKIN |
2 |
0.0000 |
| 147 |
BURNING SENSATION |
1 |
0.0000 |
| 148 |
INJURY |
1 |
0.0000 |
| 149 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 150 |
HALLUCINATION |
1 |
0.0000 |
| 151 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 152 |
DIABETES MELLITUS |
1 |
0.0000 |
| 153 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 154 |
PRODUCT USE IN UNAPPROVED INDICATION |
3 |
0.0000 |
| 155 |
BALANCE DISORDER |
1 |
0.0000 |
| 156 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 157 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 158 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 159 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 160 |
MALAISE |
5 |
0.0000 |
| 161 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 162 |
BREAST CANCER |
1 |
0.0000 |
| 163 |
CARDIAC DISORDER |
1 |
0.0000 |
| 164 |
DYSPHAGIA |
1 |
0.0000 |
| 165 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 166 |
PRURITUS |
4 |
0.0000 |
| 167 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 168 |
HEART RATE INCREASED |
1 |
0.0000 |
| 169 |
ERYTHEMA |
2 |
0.0000 |
| 170 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 171 |
HAEMORRHAGE |
1 |
0.0000 |
| 172 |
DRUG INEFFECTIVE |
12 |
0.0000 |
| 173 |
ASTHMA |
1 |
0.0000 |
| 174 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 175 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 176 |
HYPOAESTHESIA |
1 |
0.0000 |
| 177 |
TREMOR |
1 |
0.0000 |
| 178 |
FALL |
2 |
0.0000 |
| 179 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 180 |
CHEST PAIN |
1 |
0.0000 |
| 181 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 182 |
SOMNOLENCE |
1 |
0.0000 |
| 183 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 184 |
DEATH |
4 |
0.0000 |
| 185 |
WEIGHT INCREASED |
1 |
0.0000 |
| 186 |
DECREASED APPETITE |
1 |
0.0000 |
| 187 |
FEELING ABNORMAL |
1 |
0.0000 |
| 188 |
WEIGHT DECREASED |
1 |
0.0000 |
| 189 |
ANXIETY |
1 |
0.0000 |
| 190 |
HEADACHE |
2 |
0.0000 |
| 191 |
PNEUMONIA |
1 |
0.0000 |
| 192 |
NAUSEA |
2 |
0.0000 |
| 193 |
FATIGUE |
1 |
0.0000 |